<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog &#187; Anemia</title>
	<atom:link href="http://www.canadiannetmall.com/blog/tag/anemia/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.canadiannetmall.com/blog</link>
	<description></description>
	<lastBuildDate>Sat, 07 May 2011 13:51:31 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Darbepoetin alfa for Anemia of Cancer</title>
		<link>http://www.canadiannetmall.com/blog/darbepoetin-alfa-for-anemia-of-cancer/</link>
		<comments>http://www.canadiannetmall.com/blog/darbepoetin-alfa-for-anemia-of-cancer/#comments</comments>
		<pubDate>Sun, 20 Feb 2011 07:15:30 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Anemia]]></category>
		<category><![CDATA[Darbepoetin alfa]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4414</guid>
		<description><![CDATA[Interim data from a randomized, multi-center study indicate that darbepoetin alfa (Aranesp®, Amgen) is beneficial in correcting anemia in cancer patients who are not undergoing chemotherapy. The results were presented at the 45th annual meeting of the American Society of Hematology, from December 6-9, 2003 (Abstract No. 1816). The hemoglobin counts at the baseline examination [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/darbepoetin-alfa-for-anemia-of-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Labeling Changes Stronger Warnings Approved For Erythropoietic Agents</title>
		<link>http://www.canadiannetmall.com/blog/labeling-changes-stronger-warnings-approved-for-erythropoietic-agents/</link>
		<comments>http://www.canadiannetmall.com/blog/labeling-changes-stronger-warnings-approved-for-erythropoietic-agents/#comments</comments>
		<pubDate>Wed, 27 Jan 2010 15:06:26 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Drugs News]]></category>
		<category><![CDATA[Anemia]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Erythropoietic Agents]]></category>
		<category><![CDATA[Kidney disease]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=2802</guid>
		<description><![CDATA[The FDA has approved revised boxed warnings and safety-related product labeling changes for erythropoiesis-stimulating agents (ESAs), which treat certain types of anemia. ESAs are a bio-engineered version of a protein made in the kidneys that stimulates bone marrow to produce more red blood cells. A sampling of the new statements addresses the following: • Aranesp, [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/labeling-changes-stronger-warnings-approved-for-erythropoietic-agents/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Methoxy Polyethylene Glycol-Epoetin (Mircera) For Renal Anemia</title>
		<link>http://www.canadiannetmall.com/blog/methoxy-polyethylene-glycol-epoetin-mircera-for-renal-anemia/</link>
		<comments>http://www.canadiannetmall.com/blog/methoxy-polyethylene-glycol-epoetin-mircera-for-renal-anemia/#comments</comments>
		<pubDate>Mon, 25 Jan 2010 15:45:34 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Drugs News]]></category>
		<category><![CDATA[Anemia]]></category>
		<category><![CDATA[Mircera]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=2776</guid>
		<description><![CDATA[The U.S. Food and Drug Administration (FDA) has approved methoxy polyethylene glycolepoetin beta (Mircera, Roche) for the treatment of anemia associated with chronic kidney disease (CKD) in dialysis patients and in those not undergoing dialysis. Mircera is the only FDA-approved erythropoiesis-stimulating agent (ESA) to help correct anemia with dosing once every two weeks and to [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/methoxy-polyethylene-glycol-epoetin-mircera-for-renal-anemia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

